Pre-clinical data indicate that the PD-1/ PD-L1axis actively contributes to immune escape, demonstrating that PD-L1 inhibition prevented the development of a CLL-like disease in the Eμ-TCL1 mouse model67. Here, CD274 is linked to B-cell chronic lymphocytic leukemia.